REYL & Cie S.A.’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

REYL & Cie S.A.’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$98.7K	Buy	+490	New	+$106K	0.11%	86

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

REYL & Cie S.A.'s FBT Position: Q2 2026 in Review

REYL & Cie S.A. opened a new position in First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2026: 490 shares worth $98.7K. The stake represents 0.11% of the portfolio and ranks #86 among its holdings.

340 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

REYL & Cie S.A. held 490 shares of First Trust NYSE Arca Biotechnology Index Fund worth $98.7K as of Q2 2026.
First Trust NYSE Arca Biotechnology Index Fund was a new REYL & Cie S.A. position in Q2 2026.
First Trust NYSE Arca Biotechnology Index Fund made up 0.11% of REYL & Cie S.A.'s portfolio in Q2 2026, its #86 holding.
340 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on REYL & Cie S.A.'s 13F filing for Q2 2026, filed 2 Oct 2026.